Array Biopharma (ARRY) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.15 -0.28%
Revenue Growth %: -12.3%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
PKE, LNN, More
Revenue Growth %: -12.3%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.06 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $26.67 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Array Technologies (ARRY) PT Lowered to $10 at Jefferies, 'Playing Offense Amid Preferred Anxiety'
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
- Blue Owl keeps 5% redemption caps as OCIC requests ease from prior quarter
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
